Condition
Thrombotic Microangiopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Thrombotic Microangiopathy clinical trials that are recruiting, at sites in 2 countries (most in China (1), Argentina (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Iptacopan for high-risk TA-TMA after HSCT
This study tests whether taking iptacopan by mouth can help patients with high-risk transplantation-associated thrombotic microangiopathy after HSCT fail conventional initial care.
-
Thrombotic microangiopathy after allogeneic stem cell transplant in adults
This project will watch adults who receive an allogeneic stem cell transplant to see how often thrombotic microangiopathy happens and how it progresses.
Related topics
Quick answers
How many Thrombotic Microangiopathy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.